课题基金 / 基金详情

The development of a new, highly-efficacious, 100% natural, anti-viral active ingredient

The development of a new, highly-efficacious, 100% natural, anti-viral active ingredient
%20开发%20%20a%20新、%20高效、%20100%%20天然、%20抗病毒%20活性%20成分
批准号:
47612
负责人:
金额:
$44.35万
依托单位:
依托单位国家:
英国
项目类别:
Study
财政年份:
2020
资助国家:
英国
项目状态:
已结题
起止时间:
2020 至 --

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Despite rapid advances in healthcare and medical technology, viruses continue to pose a major threat to human, animal and plant health, costing economies hundreds of billions each year. Easily transmitted and immune to antibiotics, viruses (particularly non-enveloped) such as Norovirus, Polio virus and Adenovirus are very difficult to eradicate and even more expensive to treat through a limited number of antiviral solutions (£53.9bn global spend by 2025 [Grandview Research][0]). Norovirus alone kills 219k people per annum and sickens nearly 700m globally, costing £44bn per year in healthcare and lost productivity (£115m NHS cost pa) ([Telegraph][1]). Furthermore, they are becoming increasingly resistant to the current antiviral agents.Leading state of the art antiviral solutions on the market are either based upon bleach (5% active, synthetic, corrosives, hazardous to touch) or ethanol (c60% active, synthesised, requires high concentration, short-lasting benefit, dries skin out).Working in close partnership with the Department of Virology at Manchester University and based upon 4 years of research, we intend to explore and harness the highly efficacious properties of seaweed as a new, 100% natural, sustainable antiviral active ingredient for cleaning products (medium term) and medicines (long term).[0]: https://www.grandviewresearch.com/press-release/global-antiviral-drugs-market[1]: https://www.telegraph.co.uk/news/2016/04/26/norovirus-costs-the-world-some-44-billion-per-year-says-new-stud/
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
脊髓新鉴定SNAPR神经元相关环路介导SCS电刺激抑制恶性瘙痒
  • 批准号:
    82371478
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    焦英甫
  • 依托单位:
tau轻子衰变与新物理模型唯象研究
  • 批准号:
    11005033
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    18.0万元
  • 批准年份:
    2010
  • 负责人:
    李文君
  • 依托单位:
HIV gp41的NHR区新靶点的确证及高效干预
强子对撞机上新物理信号的多轻子末态研究
  • 批准号:
    10675110
  • 项目类别:
    面上项目
  • 资助金额:
    36.0万元
  • 批准年份:
    2006
  • 负责人:
    蒋一
  • 依托单位: